MAXIMUS, Inc. (NYSE:MMS) Shares Sold by Stephens Inc. AR

Stephens Inc. AR trimmed its holdings in shares of MAXIMUS, Inc. (NYSE:MMS) by 8.2% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,064 shares of the health services provider’s stock after selling 541 shares during the period. Stephens Inc. AR’s holdings in MAXIMUS were worth $440,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. Advisory Services Network LLC lifted its position in MAXIMUS by 499.0% during the second quarter. Advisory Services Network LLC now owns 593 shares of the health services provider’s stock valued at $43,000 after buying an additional 494 shares in the last quarter. Mckinley Capital Management LLC Delaware acquired a new position in MAXIMUS during the first quarter valued at approximately $44,000. Signaturefd LLC lifted its position in MAXIMUS by 19.6% during the second quarter. Signaturefd LLC now owns 1,145 shares of the health services provider’s stock valued at $83,000 after buying an additional 188 shares in the last quarter. Pearl River Capital LLC acquired a new position in MAXIMUS during the first quarter valued at approximately $88,000. Finally, Marshall Wace North America L.P. acquired a new position in MAXIMUS during the first quarter valued at approximately $119,000. 93.65% of the stock is currently owned by hedge funds and other institutional investors.

Shares of NYSE:MMS opened at $78.63 on Thursday. The company has a fifty day simple moving average of $74.41 and a 200 day simple moving average of $72.60. The firm has a market cap of $4.97 billion, a PE ratio of 23.13, a price-to-earnings-growth ratio of 2.09 and a beta of 0.88. MAXIMUS, Inc. has a 12-month low of $60.00 and a 12-month high of $80.83.

MAXIMUS (NYSE:MMS) last issued its quarterly earnings results on Thursday, August 8th. The health services provider reported $0.97 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.93 by $0.04. The business had revenue of $730.70 million during the quarter, compared to analyst estimates of $754.81 million. MAXIMUS had a net margin of 8.44% and a return on equity of 20.72%. The business’s revenue was up 22.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.91 earnings per share. As a group, analysts forecast that MAXIMUS, Inc. will post 3.73 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 30th. Shareholders of record on Thursday, August 15th will be paid a dividend of $0.25 per share. The ex-dividend date of this dividend is Wednesday, August 14th. This represents a $1.00 annualized dividend and a yield of 1.27%. MAXIMUS’s payout ratio is 29.41%.

In other MAXIMUS news, Vice Chairman Richard A. Montoni sold 12,000 shares of the business’s stock in a transaction on Tuesday, June 11th. The shares were sold at an average price of $74.07, for a total transaction of $888,840.00. Following the completion of the sale, the insider now owns 377,874 shares in the company, valued at $27,989,127.18. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Russell A. Beliveau sold 1,000 shares of the business’s stock in a transaction on Monday, July 1st. The shares were sold at an average price of $72.90, for a total transaction of $72,900.00. The disclosure for this sale can be found here. In the last quarter, insiders have sold 48,000 shares of company stock valued at $3,575,540. 2.20% of the stock is owned by insiders.

A number of brokerages have weighed in on MMS. Canaccord Genuity lifted their price objective on shares of MAXIMUS from $72.00 to $77.00 and gave the company a “hold” rating in a research note on Tuesday, August 13th. Wells Fargo & Co reiterated a “market perform” rating and set a $83.00 price objective on shares of MAXIMUS in a research note on Friday, August 9th. Zacks Investment Research upgraded shares of MAXIMUS from a “hold” rating to a “buy” rating and set a $75.00 price objective on the stock in a research note on Monday, May 27th. Finally, ValuEngine lowered shares of MAXIMUS from a “buy” rating to a “hold” rating in a research note on Friday, June 28th.

About MAXIMUS

MAXIMUS, Inc provides business process services (BPS) to government health and human services programs worldwide. The company's Health Services segment offers various BPS, appeals, and assessments for state, provincial, and national government programs, including Medicaid, Children's Health Insurance Program, Affordable Care Act, Health Insurance British Columbia, Health Assessment Advisory Service contract, and Preadmission Screening and Resident Reviews.

Recommended Story: What are trading strategies for the 52-week high/low?

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MAXIMUS, Inc. (NYSE:MMS).

Institutional Ownership by Quarter for MAXIMUS (NYSE:MMS)

Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.